{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T14:30:05Z","timestamp":1781879405290,"version":"3.54.5"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T00:00:00Z","timestamp":1721260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T00:00:00Z","timestamp":1721260800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Herzschr Elektrophys"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1007\/s00399-024-01030-0","type":"journal-article","created":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T14:02:31Z","timestamp":1721311351000},"page":"183-192","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Arrhythmien bei Schilddr\u00fcsenerkrankungen","Arrhythmias in thyroid dysfunction"],"prefix":"10.1007","volume":"35","author":[{"given":"Roman","family":"Brenner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Bilz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Busch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Rickli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Ammann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha T.","family":"Maeder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,18]]},"reference":[{"key":"1030_CR1","doi-asserted-by":"publisher","first-page":"942971","DOI":"10.3389\/fcvm.2022.942971","volume":"9","author":"P Muller","year":"2022","unstructured":"Muller\u00a0P, Leow\u00a0MK, Dietrich\u00a0JW (2022) Minor perturbations of thyroid homeostasis and major cardiovascular endpoints-Physiological mechanisms and clinical evidence. Front Cardiovasc Med 9:942971","journal-title":"Front Cardiovasc Med"},{"issue":"Suppl 2: p","key":"1030_CR2","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s00059-014-4123-0","volume":"40","author":"S Marrakchi","year":"2015","unstructured":"Marrakchi\u00a0S et\u00a0al (2015) Arrhythmia and thyroid dysfunction. Herz 40(Suppl 2: p):101\u2013109","journal-title":"Herz"},{"issue":"16","key":"1030_CR3","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1016\/j.jacc.2018.02.045","volume":"71","author":"S Razvi","year":"2018","unstructured":"Razvi\u00a0S et\u00a0al (2018) Thyroid Hormones and Cardiovascular Function and Diseases. J\u00a0Am Coll Cardiol 71(16):1781\u20131796","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"1030_CR4","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1006\/jmcc.2001.1353","volume":"33","author":"ZQ Sun","year":"2001","unstructured":"Sun\u00a0ZQ et\u00a0al (2001) Thyroid hormone increases pacemaker activity in rat neonatal atrial myocytes. J\u00a0Mol Cell Cardiol 33(4):811\u2013824","journal-title":"J Mol Cell Cardiol"},{"issue":"3","key":"1030_CR5","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/S0006-291X(03)01420-7","volume":"308","author":"H Watanabe","year":"2003","unstructured":"Watanabe\u00a0H et\u00a0al (2003) Thyroid hormone regulates mRNA expression and currents of ion channels in rat atrium. Biochem Biophys Res Commun 308(3):439\u2013444","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"1030_CR6","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1007\/s12020-019-01968-z","volume":"65","author":"J Li","year":"2019","unstructured":"Li\u00a0J et\u00a0al (2019) Alterations in atrial ion channels and tissue structure promote atrial fibrillation in hypothyroid rats. Endocrine 65(2):338\u2013347","journal-title":"Endocrine"},{"key":"1030_CR7","doi-asserted-by":"crossref","unstructured":"Tribulova, N., et\u00a0al., Thyroid hormones and cardiac arrhythmias. Vascul Pharmacol, 2010. 52(3\u20134): p.\u00a0102\u201312.","DOI":"10.1016\/j.vph.2009.10.001"},{"issue":"2","key":"1030_CR8","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/S0008-6363(98)00135-7","volume":"40","author":"A Nishiyama","year":"1998","unstructured":"Nishiyama\u00a0A et\u00a0al (1998) Effects of thyroid status on expression of voltage-gated potassium channels in rat left ventricle. Cardiovasc Res 40(2):343\u2013351","journal-title":"Cardiovasc Res"},{"key":"1030_CR9","doi-asserted-by":"crossref","unstructured":"Zawadzka K et\u00a0al (2021) Thyroid Hormones\u2014An Underestimated Player in Dilated Cardiomyopathy? J\u00a0Clin Med 10(16)","DOI":"10.3390\/jcm10163618"},{"issue":"2","key":"1030_CR10","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/S0735-1097(01)01731-4","volume":"39","author":"YC Chen","year":"2002","unstructured":"Chen\u00a0YC et\u00a0al (2002) Effects of thyroid hormone on the arrhythmogenic activity of pulmonary vein cardiomyocytes. J\u00a0Am Coll Cardiol 39(2):366\u2013372","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"1030_CR11","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1210\/jc.2008-0092","volume":"93","author":"K Wustmann","year":"2008","unstructured":"Wustmann\u00a0K et\u00a0al (2008) Activation of electrical triggers of atrial fibrillation in hyperthyroidism. J\u00a0Clin Endocrinol Metab 93(6):2104\u20132108","journal-title":"J Clin Endocrinol Metab"},{"key":"1030_CR12","doi-asserted-by":"crossref","unstructured":"Spartalis M et\u00a0al (2023) The Thyroid-cardiac Axis: Thyroid Function, Cardiac Rhythmology, and Sudden Cardiac Death. Endocr Metab Immune Disord Drug Targets","DOI":"10.2174\/0118715303243951231024112208"},{"key":"1030_CR13","doi-asserted-by":"publisher","first-page":"738517","DOI":"10.3389\/fcvm.2021.738517","volume":"8","author":"A Aweimer","year":"2021","unstructured":"Aweimer\u00a0A et\u00a0al (2021) Abnormal Cardiac Repolarization in Thyroid Diseases: Results of an Observational Study. Front Cardiovasc Med 8:738517","journal-title":"Front Cardiovasc Med"},{"key":"1030_CR14","unstructured":"Brenner R et\u00a0al (2023) Pulmonary and Systemic Hemodynamics in Patients with Hyperthyroidism. Am J Med"},{"issue":"5","key":"1030_CR15","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1161\/CIRCEP.113.000502","volume":"6","author":"Y Zhang","year":"2013","unstructured":"Zhang\u00a0Y et\u00a0al (2013) Both hypothyroidism and hyperthyroidism increase atrial fibrillation inducibility in rats. Circ Arrhythm Electrophysiol 6(5):952\u2013959","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"1030_CR16","doi-asserted-by":"crossref","unstructured":"Takawale A et\u00a0al (2022) Mechanisms and Management of Thyroid Disease and Atrial Fibrillation: Impact of Atrial Electrical Remodeling and Cardiac Fibrosis. Cells 11(24)","DOI":"10.3390\/cells11244047"},{"key":"1030_CR17","doi-asserted-by":"crossref","unstructured":"Wang, Y.Y., et\u00a0al., Excessive thyroxine enhances susceptibility to apoptosis and decreases contractility of cardiomyocytes. Mol Cell Endocrinol, 2010. 320(1\u20132): p.\u00a067\u201375.","DOI":"10.1016\/j.mce.2010.01.031"},{"issue":"e46655","key":"1030_CR18","first-page":"10","volume":"7","author":"NY Weltman","year":"2012","unstructured":"Weltman\u00a0NY et\u00a0al (2012) Longstanding hyperthyroidism is associated with normal or enhanced intrinsic cardiomyocyte function despite decline in global cardiac function. Plos One 7(e46655):10","journal-title":"Plos One"},{"issue":"1","key":"1030_CR19","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1046\/j.0300-0664.2001.01459.x","volume":"56","author":"N Komiya","year":"2002","unstructured":"Komiya\u00a0N et\u00a0al (2002) Electrophysiological abnormalities of the atrial muscle in patients with paroxysmal atrial fibrillation associated with hyperthyroidism. Clin Endocrinol (oxf) 56(1):39\u201344","journal-title":"Clin Endocrinol (oxf)"},{"issue":"9","key":"1030_CR20","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1016\/j.hrthm.2015.06.004","volume":"12","author":"W Wongcharoen","year":"2015","unstructured":"Wongcharoen\u00a0W et\u00a0al (2015) History of hyperthyroidism and long-term outcome of catheter ablation of drug-refractory atrial fibrillation. Heart Rhythm 12(9):1956\u20131962","journal-title":"Heart Rhythm"},{"issue":"2","key":"1030_CR21","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.bpj.2020.12.001","volume":"120","author":"Z Zhang","year":"2021","unstructured":"Zhang\u00a0Z et\u00a0al (2021) Mechanisms of Premature Ventricular Complexes Caused by QT Prolongation. Biophys\u00a0J 120(2):352\u2013369","journal-title":"Biophys J"},{"issue":"1","key":"1030_CR22","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0167-5273(99)00178-3","volume":"72","author":"A Altun","year":"1999","unstructured":"Altun\u00a0A, Altun\u00a0G, Ozbay\u00a0G (1999) QT dispersion in hypothyroidism. Int J Cardiol 72(1):93\u201395","journal-title":"Int J Cardiol"},{"key":"1030_CR23","doi-asserted-by":"crossref","unstructured":"Le Bouter, S., et\u00a0al., Microarray analysis reveals complex remodeling of cardiac ion channel expression with altered thyroid status: relation to cellular and integrated electrophysiology. Circ Res, 2003. 92(2): p.\u00a0234\u201342.","DOI":"10.1161\/01.RES.0000053185.75505.8E"},{"issue":"1","key":"1030_CR24","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1677\/JOE-08-0140","volume":"198","author":"C van Noord","year":"2008","unstructured":"van Noord\u00a0C et\u00a0al (2008) High free thyroxine levels are associated with QTc prolongation in males. J\u00a0Endocrinol 198(1):253\u2013260","journal-title":"J Endocrinol"},{"issue":"3","key":"1030_CR25","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1111\/j.1365-2125.2009.03474.x","volume":"68","author":"C van Noord","year":"2009","unstructured":"van Noord\u00a0C et\u00a0al (2009) Population-based studies of antithyroid drugs and sudden cardiac death. Br J Clin Pharmacol 68(3):447\u2013454","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"1030_CR26","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1046\/j.1365-2265.2001.01295.x","volume":"55","author":"RM Colzani","year":"2001","unstructured":"Colzani\u00a0RM et\u00a0al (2001) Hyperthyroidism is associated with lengthening of ventricular repolarization. Clin Endocrinol (oxf) 55(1):27\u201332","journal-title":"Clin Endocrinol (oxf)"},{"issue":"Suppl 2: p","key":"1030_CR27","doi-asserted-by":"publisher","first-page":"S91","DOI":"10.33549\/physiolres.931557","volume":"57","author":"V Knezl","year":"2008","unstructured":"Knezl\u00a0V et\u00a0al (2008) Thyroid hormones modulate occurrence and termination of ventricular fibrillation by both long-term and acute actions. Physiol Res 57(Suppl 2: p):S91\u2013S96","journal-title":"Physiol Res"},{"issue":"2","key":"1030_CR28","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/0002-8703(86)90272-3","volume":"112","author":"RJ Northcote","year":"1986","unstructured":"Northcote\u00a0RJ et\u00a0al (1986) Continuous 24-hour electrocardiography in thyrotoxicosis before and after treatment. Am Heart\u00a0J 112(2):339\u2013344","journal-title":"Am Heart J"},{"key":"1030_CR29","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.jelectrocard.2020.07.002","volume":"62","author":"A Lee","year":"2020","unstructured":"Lee\u00a0A et\u00a0al (2020) Right ventricular outflow tract ventricular tachycardia as a\u00a0result of uncontrolled hyperthyroidism. J\u00a0Electrocardiol 62:110\u2013112","journal-title":"J Electrocardiol"},{"key":"1030_CR30","doi-asserted-by":"crossref","unstructured":"Frost, L., P.\u00a0Vestergaard, and L.\u00a0Mosekilde, Hyperthyroidism and risk of atrial fibrillation or flutter: a\u00a0population-based study. Arch Intern Med, 2004. 164(15): p.\u00a01675\u20138.","DOI":"10.1001\/archinte.164.15.1675"},{"issue":"4","key":"1030_CR31","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1111\/jocs.12513","volume":"30","author":"B Worku","year":"2015","unstructured":"Worku\u00a0B et\u00a0al (2015) Preoperative hypothyroidism is a\u00a0risk factor for postoperative atrial fibrillation in cardiac surgical patients. J\u00a0Card Surg 30(4):307\u2013312","journal-title":"J Card Surg"},{"issue":"22","key":"1030_CR32","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1161\/CIRCULATIONAHA.117.028753","volume":"136","author":"C Baumgartner","year":"2017","unstructured":"Baumgartner\u00a0C et\u00a0al (2017) Thyroid Function Within the Normal Range, Subclinical Hypothyroidism, and the Risk of Atrial Fibrillation. Circulation 136(22):2100\u20132116","journal-title":"Circulation"},{"issue":"19","key":"1030_CR33","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1056\/NEJM199411103311901","volume":"331","author":"CT Sawin","year":"1994","unstructured":"Sawin\u00a0CT et\u00a0al (1994) Low serum thyrotropin concentrations as a\u00a0risk factor for atrial fibrillation in older persons. N\u00a0Engl J Med 331(19):1249\u20131252","journal-title":"N Engl J Med"},{"issue":"9","key":"1030_CR34","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1001\/jama.295.9.1033","volume":"295","author":"AR Cappola","year":"2006","unstructured":"Cappola\u00a0AR et\u00a0al (2006) Thyroid status, cardiovascular risk, and mortality in older adults. JAMA 295(9):1033\u20131041","journal-title":"JAMA"},{"issue":"9","key":"1030_CR35","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1001\/archinte.167.9.928","volume":"167","author":"MD Gammage","year":"2007","unstructured":"Gammage\u00a0MD et\u00a0al (2007) Association between serum free thyroxine concentration and atrial fibrillation. Arch Intern Med 167(9):928\u2013934","journal-title":"Arch Intern Med"},{"issue":"13","key":"1030_CR36","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/0002-9149(89)90142-2","volume":"63","author":"K von Olshausen","year":"1989","unstructured":"von Olshausen\u00a0K et\u00a0al (1989) Cardiac arrhythmias and heart rate in hyperthyroidism. Am J Cardiol 63(13):930\u2013933","journal-title":"Am J Cardiol"},{"key":"1030_CR37","doi-asserted-by":"crossref","unstructured":"Biondi, B., et\u00a0al., Clinical case seminar: Reentrant atrioventricular nodal tachycardia induced by levothyroxine. J\u00a0Clin Endocrinol Metab, 1998. 83(8): p.\u00a02643\u20135.","DOI":"10.1210\/jc.83.8.2643"},{"issue":"19","key":"1030_CR38","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1001\/archinte.1996.00440180083010","volume":"156","author":"AD Krahn","year":"1996","unstructured":"Krahn\u00a0AD et\u00a0al (1996) How useful is thyroid function testing in patients with recent-onset atrial fibrillation? The Canadian Registry of Atrial Fibrillation Investigators. Arch Intern Med 156(19):2221\u20132224","journal-title":"Arch Intern Med"},{"issue":"1","key":"1030_CR39","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/0002-9149(79)90243-1","volume":"44","author":"JC Forfar","year":"1979","unstructured":"Forfar\u00a0JC, Miller\u00a0HC, Toft\u00a0AD (1979) Occult thyrotoxicosis: a\u00a0correctable cause of \u201cidiopathic\u201d atrial fibrillation. Am J Cardiol 44(1):9\u201312","journal-title":"Am J Cardiol"},{"issue":"5","key":"1030_CR40","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"G Hindricks","year":"2021","unstructured":"Hindricks\u00a0G et\u00a0al (2021) 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart\u00a0J 42(5):373\u2013498","journal-title":"Eur Heart J"},{"issue":"6","key":"1030_CR41","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/0002-9343(82)90850-6","volume":"72","author":"HK Nakazawa","year":"1982","unstructured":"Nakazawa\u00a0HK et\u00a0al (1982) Management of atrial fibrillation in the post-thyrotoxic state. Am J Med 72(6):903\u2013906","journal-title":"Am J Med"},{"issue":"24","key":"1030_CR42","doi-asserted-by":"publisher","first-page":"2947","DOI":"10.2169\/internalmedicine.50.6135","volume":"50","author":"ZH Zhou","year":"2011","unstructured":"Zhou\u00a0ZH, Ma\u00a0LL, Wang\u00a0LX (2011) Risk factors for persistent atrial fibrillation following successful hyperthyroidism treatment with radioiodine therapy. Intern Med 50(24):2947\u20132951","journal-title":"Intern Med"},{"issue":"6","key":"1030_CR43","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1089\/thy.2022.0392","volume":"33","author":"J Fazendin","year":"2023","unstructured":"Fazendin\u00a0J et\u00a0al (2023) Surgical Treatment of Hyperthyroidism Can Be Performed Safely Before a\u00a0Euthyroid State is Achieved. Thyroid 33(6):691\u2013696","journal-title":"Thyroid"},{"key":"1030_CR44","doi-asserted-by":"publisher","first-page":"795492","DOI":"10.3389\/fendo.2021.795492","volume":"12","author":"B Gencer","year":"2021","unstructured":"Gencer\u00a0B et\u00a0al (2021) Challenges in the Management of Atrial Fibrillation With Subclinical Hyperthyroidism. Front Endocrinol (lausanne) 12:795492","journal-title":"Front Endocrinol (lausanne)"},{"issue":"3","key":"1030_CR45","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1159\/000438750","volume":"4","author":"B Biondi","year":"2015","unstructured":"Biondi\u00a0B et\u00a0al (2015) The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism. Eur Thyroid\u00a0J 4(3):149\u2013163","journal-title":"Eur Thyroid J"},{"issue":"15","key":"1030_CR46","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1056\/NEJMoa1001337","volume":"362","author":"IC Van Gelder","year":"2010","unstructured":"Van Gelder\u00a0IC et\u00a0al (2010) Lenient versus strict rate control in patients with atrial fibrillation. N\u00a0Engl J Med 362(15):1363\u20131373","journal-title":"N Engl J Med"},{"key":"1030_CR47","doi-asserted-by":"crossref","unstructured":"Joglar, J.A., et\u00a0al., 2023 ACC\/AHA\/ACCP\/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A\u00a0Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation, 2024. 149(1): p. e1\u2013e156.","DOI":"10.1161\/CIR.0000000000001207"},{"issue":"3","key":"1030_CR48","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1159\/000356954","volume":"127","author":"Q Chen","year":"2014","unstructured":"Chen\u00a0Q et\u00a0al (2014) Effect of hyperthyroidism on the hypercoagulable state and thromboembolic events in patients with atrial fibrillation. Cardiology 127(3):176\u2013182","journal-title":"Cardiology"},{"issue":"1","key":"1030_CR49","first-page":"15","volume":"19","author":"P Petersen","year":"1988","unstructured":"Petersen\u00a0P, Hansen\u00a0JM (1988) stroke Thyrotoxicosis With Atr Fibrillation Stroke 19(1):15\u201318","journal-title":"stroke Thyrotoxicosis With Atr Fibrillation Stroke"},{"issue":"12","key":"1030_CR50","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1093\/eurheartj\/ehr488","volume":"33","author":"L Friberg","year":"2012","unstructured":"Friberg\u00a0L, Rosenqvist\u00a0M, Lip\u00a0GY (2012) Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study. Eur Heart\u00a0J 33(12):1500\u20131510","journal-title":"Eur Heart J"},{"issue":"6","key":"1030_CR51","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1089\/105072502760143863","volume":"12","author":"T Shimizu","year":"2002","unstructured":"Shimizu\u00a0T et\u00a0al (2002) Hyperthyroidism and the management of atrial fibrillation. Thyroid 12(6):489\u2013493","journal-title":"Thyroid"},{"issue":"23","key":"1030_CR52","first-page":"8502","volume":"22","author":"MA Perrone","year":"2018","unstructured":"Perrone\u00a0MA et\u00a0al (2018) Efficacy and safety of dronedarone in patients with amiodarone-induced hyperthyroidism: a\u00a0clinical study. Eur Rev Med Pharmacol Sci 22(23):8502\u20138508","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"e010200","key":"1030_CR53","first-page":"11","volume":"14","author":"P Krisai","year":"2021","unstructured":"Krisai\u00a0P et\u00a0al (2021) Catheter Ablation for Atrial Fibrillation in Hyperthyroid Patients. Circ Arrhythm Electrophysiol 14(e010200):11","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"8","key":"1030_CR54","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1111\/jce.12140","volume":"24","author":"EN Mikhaylov","year":"2013","unstructured":"Mikhaylov\u00a0EN et\u00a0al (2013) Catheter ablation of paroxysmal atrial fibrillation in patients with previous amiodarone-induced hyperthyroidism: a\u00a0case-control study. J\u00a0Cardiovasc Electrophysiol 24(8):888\u2013893","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"4","key":"1030_CR55","doi-asserted-by":"publisher","first-page":"416","DOI":"10.5603\/CJ.a2016.0029","volume":"23","author":"M Wang","year":"2016","unstructured":"Wang\u00a0M et\u00a0al (2016) Safety and efficacy of early radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation complicated with amiodarone-induced thyrotoxicosis. Cardiol\u00a0J 23(4):416\u2013421","journal-title":"Cardiol J"},{"issue":"12","key":"1030_CR56","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1016\/j.amjcard.2015.09.028","volume":"116","author":"PA Sousa","year":"2015","unstructured":"Sousa\u00a0PA et\u00a0al (2015) Impact of Free Thyroxine on the Outcomes of Left Atrial Ablation Procedures. Am J Cardiol 116(12):1863\u20131868","journal-title":"Am J Cardiol"},{"issue":"7","key":"1030_CR57","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1001\/archinte.1982.00340200130024","volume":"142","author":"J Fisher","year":"1982","unstructured":"Fisher\u00a0J (1982) Thyrotoxic periodic paralysis with ventricular fibrillation. Arch Intern Med 142(7):1362\u20131364","journal-title":"Arch Intern Med"},{"issue":"10","key":"1030_CR58","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1161\/CIRCULATIONAHA.115.020789","volume":"134","author":"L Chaker","year":"2016","unstructured":"Chaker\u00a0L et\u00a0al (2016) Thyroid Function and Sudden Cardiac Death: A\u00a0Prospective Population-Based Cohort Study. Circulation 134(10):713\u2013722","journal-title":"Circulation"},{"issue":"8","key":"1030_CR59","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1016\/j.amjcard.2020.01.019","volume":"125","author":"P Muller","year":"2020","unstructured":"Muller\u00a0P et\u00a0al (2020) Usefulness of Serum Free Thyroxine Concentration to Predict Ventricular Arrhythmia Risk in Euthyroid Patients With Structural Heart Disease. Am J Cardiol 125(8):1162\u20131169","journal-title":"Am J Cardiol"},{"issue":"1","key":"1030_CR60","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1002\/clc.23117","volume":"42","author":"X Li","year":"2019","unstructured":"Li\u00a0X et\u00a0al (2019) Thyroid-stimulating hormone within the normal range and risk of major adverse cardiovascular events in nonischemic dilated cardiomyopathy patients with severe left ventricular dysfunction. Clin Cardiol 42(1):120\u2013128","journal-title":"Clin Cardiol"},{"issue":"3","key":"1030_CR61","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1111\/j.0954-6820.1983.tb03724.x","volume":"213","author":"BO Fredlund","year":"1983","unstructured":"Fredlund\u00a0BO, Olsson\u00a0SB (1983) Long QT interval and ventricular tachycardia of \u201ctorsade de pointe\u201d type in hypothyroidism. Acta Med Scand 213(3):231\u2013235","journal-title":"Acta Med Scand"},{"issue":"1","key":"1030_CR62","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/j.1476-5381.1989.tb16867.x","volume":"98","author":"R Chess-Williams","year":"1989","unstructured":"Chess-Williams\u00a0R, Coker\u00a0SJ (1989) Ventricular fibrillation is reduced in hypothyroid rats with enhanced myocardial alpha-adrenoceptor responsiveness. Br J Pharmacol 98(1):95\u2013100","journal-title":"Br J Pharmacol"},{"issue":"12","key":"1030_CR63","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1046\/j.1460-9592.2001.01827.x","volume":"24","author":"ME Marketou","year":"2001","unstructured":"Marketou\u00a0ME et\u00a0al (2001) Electrical storm due to amiodarone induced thyrotoxicosis in a\u00a0young adult with dilated cardiomyopathy: thyroidectomy as the treatment of choice. Pacing Clin Electrophysiol 24(12):1827\u20131828","journal-title":"Pacing Clin Electrophysiol"}],"container-title":["Herzschrittmachertherapie + Elektrophysiologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00399-024-01030-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00399-024-01030-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00399-024-01030-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T11:03:45Z","timestamp":1724670225000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00399-024-01030-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,18]]},"references-count":63,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["1030"],"URL":"https:\/\/doi.org\/10.1007\/s00399-024-01030-0","relation":{},"ISSN":["0938-7412","1435-1544"],"issn-type":[{"value":"0938-7412","type":"print"},{"value":"1435-1544","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,18]]},"assertion":[{"value":"18 June 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"R.\u00a0Brenner, S.\u00a0Bilz, S.\u00a0Busch, H.\u00a0Rickli, P.\u00a0Ammann und M.T.\u00a0Maeder geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}